These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18333423)

  • 1. "The trouble with QALYs...".
    Knapp M; Mangalore R
    Epidemiol Psichiatr Soc; 2007; 16(4):289-93. PubMed ID: 18333423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
    Jia H; Zack MM; Moriarty DG; Fryback DG
    Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK.
    Matza LS; Secnik K; Mannix S; Sallee FR
    Pharmacoeconomics; 2005; 23(8):777-90. PubMed ID: 16097840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
    Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
    Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
    Günther OH; Roick C; Angermeyer MC; König HH
    J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future Directions in Valuing Benefits for Estimating QALYs: Is Time Up for the EQ-5D?
    Brazier JE; Rowen D; Lloyd A; Karimi M
    Value Health; 2019 Jan; 22(1):62-68. PubMed ID: 30661635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice Defines QALYs: A US Valuation of the EQ-5D-5L.
    Craig BM; Rand K
    Med Care; 2018 Jun; 56(6):529-536. PubMed ID: 29668646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial.
    Wu AW; Jacobson KL; Frick KD; Clark R; Revicki DA; Freedberg KA; Scott-Lennox J; Feinberg J
    Qual Life Res; 2002 May; 11(3):273-82. PubMed ID: 12074264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of psychiatric disorders on health-related quality of life: general population survey.
    Saarni SI; Suvisaari J; Sintonen H; Pirkola S; Koskinen S; Aromaa A; Lönnqvist J
    Br J Psychiatry; 2007 Apr; 190():326-32. PubMed ID: 17401039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
    Crick K; Al Sayah F; Ohinmaa A; Johnson JA
    Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The responsiveness of the EQ-5D and time trade-off scores in schizophrenia, affective disorders, and alcohol addiction.
    Sonntag M; König HH; Konnopka A
    Health Qual Life Outcomes; 2015 Jul; 13():114. PubMed ID: 26530986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility, validity and reliability of the Welsh version of the EQ-5D health status questionnaire.
    Hughes DA
    Qual Life Res; 2007 Oct; 16(8):1419-23. PubMed ID: 17653613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the Benefits of Healthcare: DALYs and QALYs - Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions.
    Augustovski F; Colantonio LD; Galante J; Bardach A; Caporale JE; Zárate V; Chuang LH; Pichon-Riviere A; Kind P
    Int J Health Policy Manag; 2018 Feb; 7(2):120-136. PubMed ID: 29524936
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.